Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil

@article{Selbst2009SpectrumOH,
  title={Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil},
  author={Megan K Selbst and William Albert Ahrens and Marie E. Robert and Amy L Friedman and D. D. Proctor and D Jain},
  journal={Modern Pathology},
  year={2009},
  volume={22},
  pages={737-743}
}
Mycophenolate mofetil, an immunosuppressive agent, is frequently used following bone marrow and solid organ transplantation. Diarrhea is a commonly seen side effect of mycophenolate mofetil, which may necessitate colonic biopsy in some patients. The histologic changes found in this setting have been reported to mimic self-limited colitis, graft-vs-host disease or inflammatory bowel disease in isolated case reports, and could pose diagnostic and management difficulties. The goal of this study is… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 32 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 21 references

Conver - sion from mycophenolate mofetil to enteric - coated mycophenolate sodium in stable maintenance renal transplant patients : pooled results from three international , multicenter studies

  • JC Papadimitriou, CB Cangro, A Lustberg
  • Transplant Proc
  • 2007

Hoffman-La Roche receives FDA approval to market CellCept for preventing liver transplant rejection. Transplant News; advance online publication

  • M. Ziriakus
  • August 28,
  • 2000

Similar Papers

Loading similar papers…